Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 29
Filtrar
1.
Am J Dermatopathol ; 40(10): 721-726, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29570128

RESUMO

Adenoid cystic carcinoma (ACC) of the skin is a rare malignant neoplasm histologically identical to homonymous tumors in other organs. Cutaneous ACC has been found to harbor MYB gene activations, either through MYB chromosomal abnormalities or by generation of the MYB-NFIB fusion. In salivary gland ACC, in addition to the MYB gene, alterations in MYBL1, the gene closely related to MYB, have been reported. We studied 10 cases of cutaneous ACC (6 women, 4 men; and age range 51-83 years) for alterations in the MYB, NFIB, and MYBL1 genes, using FISH and PCR. MYB break-apart and NFIB break-apart tests were positive in 4 and 5 cases, respectively. MYB-NFIB fusions were found in 4 cases. The break of MYBL1 was found in 2 cases, and in one of them, the NFIB break-apart probe was positive, strongly indicating a MYBL1-NFIB fusion. In 2 cases, the MYB break-apart test was positive, whereas no MYB-NFIB was detected, strongly suggesting another fusion partner. It is concluded that MYBL1 alterations are detected in primary cutaneous ACC but are apparently less common compared with MYB and NFIB alterations.


Assuntos
Biomarcadores Tumorais/genética , Carcinoma Adenoide Cístico/genética , Proteínas Proto-Oncogênicas/genética , Neoplasias Cutâneas/genética , Transativadores/genética , Idoso , Idoso de 80 Anos ou mais , Carcinoma Adenoide Cístico/patologia , Feminino , Fusão Gênica , Rearranjo Gênico , Predisposição Genética para Doença , Humanos , Imuno-Histoquímica , Hibridização in Situ Fluorescente , Masculino , Pessoa de Meia-Idade , Fatores de Transcrição NFI/genética , Proteínas de Fusão Oncogênica/genética , Fenótipo , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Neoplasias Cutâneas/patologia
2.
Ann Diagn Pathol ; 27: 48-56, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28325361

RESUMO

Oncocytic papillary renal cell carcinoma (PRCC) is a distinct subtype of PRCC, listed as a possible new variant of PRCC in the 2016 WHO classification. It is composed of papillae aligned by large single-layered eosinophilic cells showing linearly arranged oncocytoma-like nuclei. We analyzed clinicopathologic, morphologic, immunohistochemical and molecular-genetic characteristics of 11 oncocytic PRCCs with prominent tumor lymphocytic infiltrate, morphologically resembling Warthin's tumor. The patients were predominantly males (8/11, 73%), with an average age of 59years (range 14-76), and a mean tumor size of 7cm (range 1-22cm). Tumors had the features of oncocytic PRCCs with focal pseudostratification in 8/11 cases and showed dense stromal inflammatory infiltration in all cases. Papillary growth pattern was predominant, comprising more than 60% of tumor volume. Tubular and solid components were present in 5 and 3 cases, respectively. Uniform immunohistochemical positivity was found for AMACR, PAX-8, MIA, vimentin, and OSCAR. Tumors were mostly negative for carboanhydrase 9, CD117, CK20, and TTF-1. Immunohistochemical stains for DNA mismatch repair proteins MLH1 and PMS2 were retained in all cases, while MSH2 and MSH6 were negative in 1 case. Tumor infiltrating lymphocytes (TILs) consisted of both B and T cells. Chromosomal copy number variation analysis showed great variability in 5 cases, ranging from a loss of one single chromosome to complex genome rearrangements. Only one case showed gains of chromosomes 7 and 17, among other aberrations. In 4 cases no numerical imbalance was found. Follow up data was available for 9 patients (median 47.6months, range 1-132). In 6 patients no lethal progression was noted, while 3 died of disease. In conclusion, Warthin-like PRCC is morphologically very close to oncocytic PRCC, from which it differs by the presence of dense lymphoid stroma. Chromosomal numerical aberration pattern of these tumors is variable; only one case showed gains of chromosomes 7 and 17. Warthin-like PRCC is a potentially aggressive tumor since a lethal outcome was recorded in 3/9 cases.


Assuntos
Carcinoma Papilar/patologia , Carcinoma de Células Renais/genética , Carcinoma de Células Renais/patologia , Neoplasias Renais/genética , Neoplasias Renais/patologia , Adenoma Oxífilo/genética , Adenoma Oxífilo/patologia , Adolescente , Idoso , Biomarcadores Tumorais/análise , Carcinoma Papilar/genética , Carcinoma de Células Renais/diagnóstico , Variações do Número de Cópias de DNA/genética , Feminino , Predisposição Genética para Doença , Testes Genéticos/métodos , Humanos , Imuno-Histoquímica/métodos , Hibridização in Situ Fluorescente/métodos , Neoplasias Renais/diagnóstico , Masculino , Pessoa de Meia-Idade
3.
Adv Anat Pathol ; 23(6): 381-384, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27740962

RESUMO

We describe a case of an unusual endometrial endometrioid carcinoma occurring in a 67-year-old woman. The tumor involved uterine corpus as well as lower uterine segment and presented as polypoid tumor protruding through the cervical orifice. Microscopically, the tumor was characterized by broad zones of cytologically bland fibromyxoid stroma resembling nodular fasciitis, showing vaguely nodular architecture. Neoplastic glands were characterized by interconnected elongated slit-like and large cystic profiles, mostly lined by flattened epithelium with variable squamous differentiation, whereas typical columnar endometrioid cells were only focally present. Voluminous nodules of the stroma produced phyllodes-like appearance of the tumor. The tumor showed some resemblance to the microcystic, elongated, and fragmented (MELF) glands growth pattern, but in contrast with MELF pattern, where fibromyxoid change occurs focally, in the presented case abundant myofibroblastic proliferation was present throughout the tumor and the neoplastic glands showed anastomosing "large cystic" rather than "small cystic" profiles. Some of the neoplastic glands presented almost complete or complete squamous differentiation, with relatively bland-looking squamous cells and no hint of endometrioid differentiation, which resulted in initial misdiagnosis of Müllerian adenofibroma. We believe that nodular fasciitis-like pattern represents yet undescribed, and diagnostically challenging pattern of invasion in endometrial endometrioid carcinoma.


Assuntos
Carcinoma Endometrioide/patologia , Neoplasias do Endométrio/patologia , Idoso , Biomarcadores Tumorais/análise , Cistos/patologia , Fasciite/patologia , Feminino , Humanos , Imuno-Histoquímica
4.
Life (Basel) ; 13(7)2023 Jul 23.
Artigo em Inglês | MEDLINE | ID: mdl-37511985

RESUMO

BACKGROUND: The optimal hypofractionated schedule of post-prostatectomy radiotherapy remains to be established. We evaluated treatment outcomes and toxicity of moderately hypofractionated post-prostatectomy radiotherapy in 16 daily fractions delivered with intensity-modulated radiotherapy. The treatment schedule selection was motivated by limited technology resources and was radiobiologically dose-escalated. METHODS: One hundred consecutive M0 patients with post-prostatectomy radiotherapy were evaluated. Radiotherapy indication was adjuvant (ART) in 19%, early-salvage (eSRT) in 46% and salvage (SRT) in 35%. The dose prescription for prostate bed planning target volume was 52.8 Gy in 16 fractions of 3.3 Gy. The Common Terminology Criteria v. 4 for Adverse Events scale was used for toxicity grading. RESULTS: The median follow-up was 61 months. Five-year biochemical recurrence-free survival (bRFS) was 78.6%, distant metastases-free survival (DMFS) was 95.7% and overall survival was 98.8%. Treatment indication (ART or eSRT vs. SRT) was the only significant factor for bRFS (HR 0.15, 95% CI 0.05-0.47, p = 0.001) and DMFS (HR 0.16, 95% CI 0.03-0.90; p = 0.038). Acute gastrointestinal (GI) toxicity grade 2 was recorded in 24%, grade 3 in 2%, acute genitourinary (GU) toxicity grade 2 in 10% of patients, and no grade 3. A cumulative rate of late GI toxicity grade ≥ 2 was observed in 9% and late GU toxicity grade ≥ 2 in 16% of patients. CONCLUSIONS: The observed results confirmed efficacy and showed a higher than anticipated rate of early GI, late GI, and GU toxicity of post-prostatectomy radiobiologically dose-escalated hypofractionated radiotherapy in 16 daily fractions.

5.
Cancers (Basel) ; 14(21)2022 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-36358801

RESUMO

Over the last two decades, human papillomavirus (HPV) has caused a new pandemic of cancer in many urban areas across the world. The new entity, HPV-associated oropharyngeal squamous cell carcinoma (OPSCC), has been at the center of scientific attention ever since, not only due to its distinct biological behavior, but also because of its significantly better prognosis than observed in its HPV-negative counterpart. The very good treatment outcomes of the disease after primary therapy (minimally-invasive surgery, radiation therapy with or without chemotherapy) resulted in the creation of a separate staging system, reflecting this excellent prognosis. A substantial proportion of newly diagnosed HPV-driven OPSCC is diagnosed in stage I or II, where long-term survival is observed worldwide. Deintensification of the primary therapeutic methods, aiming at a reduction of long-term toxicity in survivors, has emerged, and the quality of life of the patient after treatment has become a key-point in many clinical trials. Current treatment recommendations for the treatment of HPV-driven OPSCC do not differ significantly from HPV-negative OPSCC; however, the results of randomized trials are eagerly awaited and deemed necessary, in order to include deintensification into standard clinical practice.

6.
Head Neck ; 43(1): 354-366, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-32996265

RESUMO

Management of patients with recurrent head and neck cancer remains a challenge for the surgeon as well as the treating radiation oncologist. Even in the era of modern radiotherapy, the rate of severe toxicity remains high with unsatisfactory treatment results. Intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and heavy-ion irradiation have all emerged as highly conformal and precise techniques that offer many radiobiological advantages in various clinical situations. Although re-irradiation is now widespread in clinical practice, little is known about the differences in treatment response and toxicity using diverse re-irradiation techniques. In this review, we provide a comprehensive overview of the role of radiation therapy in recurrent or second primary head and neck cancer including patient selection, therapeutic outcome, and risk using different re-irradiation techniques. Critical review of published evidence on IMRT, SBRT, and heavy-ion full-dose re-irradiation is presented including data on locoregional control, overall survival, and toxicity.


Assuntos
Neoplasias de Cabeça e Pescoço , Radiocirurgia , Radioterapia de Intensidade Modulada , Reirradiação , Neoplasias de Cabeça e Pescoço/radioterapia , Humanos , Recidiva Local de Neoplasia/radioterapia , Radioterapia de Intensidade Modulada/efeitos adversos
7.
Cancers (Basel) ; 12(12)2020 Nov 25.
Artigo em Inglês | MEDLINE | ID: mdl-33255751

RESUMO

Recurrent nasopharyngeal carcinoma represents an extremely challenging therapeutic situation. Given the vulnerability of the already pretreated neurological structures surrounding the nasopharynx, any potential salvage retreatment option bears a significant risk of severe complications that result in high treatment-related morbidity, quality of life deterioration, and even mortality. Yet, with careful patient selection, long-term survival may be achieved after local retreatment in a subgroup of patients with local or regional relapse of nasopharyngeal cancer. Early detection of the recurrence represents the key to therapeutic success, and in the case of early stage disease, several curative treatment options can be offered to the patient, albeit with minimal support in prospective clinical data. In this article, an up-to-date review of published evidence on modern surgical and radiation therapy treatment options is summarized, including currently recommended treatment modifications of both therapeutic approaches during the coronavirus disease 2019 pandemic.

8.
Wiad Parazytol ; 55(4): 429-31, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20209820

RESUMO

Dirofilariosis is a parasitic disease caused by helminths of the genus Dirofilaria. Climatic changes are considered to be main risk factors for dirofilariosis spreading. In the Slovak Republic, canine subcutaneous dirofilariosis was recorded for the first time in 2005. In 2007 the first coordinated research project started to detect possible endemic infections and to determine their magnitude. A total of 984 dogs were examined for the presence of microfilariae within 2007-2008. Modified Knott test and PCR were used for microfilariae detection and for Dirofilaria species identification. Dirofilariosis was diagnosed in 196 dogs which represents an overall prevalence of 19.9%. The majority of infected dogs came from southern regions of Slovakia. In the regions of Trnava and Nitra 45.2% and 31.4% of the dogs surveyed were infected, respectively. The highest prevalence of dirofilariosis was detected in shepherd and watch dogs (45.7%), and hunting dogs (40.5%). In the group of police dogs, 20.5% animals were infected. Dirofilaria repens was detected in all infected dogs. In seven animals co-infection with Dirofilaria immitis was present.


Assuntos
Mudança Climática/estatística & dados numéricos , Dirofilaria/isolamento & purificação , Dirofilariose/epidemiologia , Dirofilariose/parasitologia , Doenças do Cão/epidemiologia , Doenças do Cão/parasitologia , Animais , Dirofilariose/diagnóstico , Doenças do Cão/diagnóstico , Cães , Prevalência , Fatores de Risco , Eslováquia/epidemiologia
9.
Front Oncol ; 8: 30, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29527511

RESUMO

While there are no established pretreatment predictive and prognostic factors in patients with stage IIIA/pN2 non-small cell lung cancer (NSCLC) indicating a benefit to surgery as a part of trimodality approach, little is known about treatment-related predictive and prognostic factors in this setting. A literature search was conducted to identify possible treatment-related predictive and prognostic factors for patients for whom trimodality approach was reported on. Overall survival was the primary endpoint of this study. Of 30 identified studies, there were two phase II studies, 5 "prospective" studies, and 23 retrospective studies. No study was found which specifically looked at treatment-related predictive factors of improved outcomes in trimodality treatment. Of potential treatment-related prognostic factors, the least frequently analyzed factors among 30 available studies were overall pathologic stage after preoperative treatment and UICC downstaging. Evaluation of treatment response before surgery and by pathologic tumor stage after induction therapy were analyzed in slightly more than 40% of studies and found not to influence survival. More frequently studied factors-resection status, degree of tumor regression, and pathologic nodal stage after induction therapy as well as the most frequently studied factor, the treatment (in almost 75% studies)-showed no discernible impact on survival, due to conflicting results. Currently, it is impossible to identify any treatment-related predictive or prognostic factors for selecting surgery in the treatment of patients with stage IIIA/pN2 NSCLC.

10.
Ann Agric Environ Med ; 14(1): 71-3, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17655180

RESUMO

Toxoplasma gondii is a protozoan parasite of great medical and veterinary importance. The aim of this study was to determine the seroprevalence of toxoplasmosis in wild boars hunted in the Slovak Republic in 2003. Examination of 320 wild boars revealed a seroprevalence of 8.1%. The majority of seropositive wild boars came from the north-western and southern regions of Slovakia. This study indicates that T. gondii infection is common in wild boars in the Slovak Republic, underlines its zoonotic potential and the importance of high standards of hygiene during the handling of game.


Assuntos
Anticorpos Antiprotozoários/sangue , Sus scrofa , Toxoplasma/imunologia , Toxoplasmose Animal/epidemiologia , Animais , Feminino , Humanos , Masculino , Fatores de Risco , Estudos Soroepidemiológicos , Eslováquia/epidemiologia , Toxoplasmose Animal/transmissão , Zoonoses
11.
Front Oncol ; 7: 169, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28848708

RESUMO

Lung cancer is the major cancer killer in the Western world, with the small cell lung cancer (SCLC) representing around 15-20% of all lung cancers. Extensive disease small cell lung cancer (ED SCLC) is found in approximately two-thirds of all cases, composed of both metastatic (M1) and non-metastatic (but presumably with tumor burden too large for locoregional-only approach) variant. Standard treatment options involve chemotherapy (CHT) over the past several decades. Radiation therapy (RT) had mostly been used in palliation of locoregional and/or metastatic disease. In contrast to its established role in treating metastatic disease, thoracic RT (TRT) had never been established as important part of the treatment aspects in this setting. In the past two decades, thoracic oncologists have witnessed wide introduction of modern RT and CHT aspects in ED SCLC, which led to more frequent use of RT and rise in the number of clinical studies. Since the pivotal study of Jeremic et al., who were the first to show importance of TRT in ED SCLC, a number of single-institutional studies have reconfirmed this observation, while recent prospective randomized trials (CREST and RTOG 0937) brought more substance to this issue. Similarly, the issue of prophylactic cranial irradiation was investigated in EORTC and the Japanese study, respectively, bringing somewhat conflicting results and calling for additional research in this setting. Future studies in ED SCLC could incorporate questions of RT dose and fractionation as well as the number of CHT cycles and type of combined Rt-CHT (sequential vs concurrent).

12.
J Radiat Res ; 58(3): 267-272, 2017 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-28339761

RESUMO

Recent years have witnessed a number of clinical trials in Stage IIIA non-small cell lung cancer (NSCLC) comparing (A) induction chemotherapy (CHT) with induction CHT and radiotherapy (RT), each followed by surgery; (B) either induction CHT or induction RT-CHT, each followed by surgery, with definitive RT-CHT (no surgery). Due to the heterogeneity of patient, tumor and treatment characteristics across these trials, various meta-analyses (MAs) have been performed to define the optimal treatment approach in this setting for this clinical presentation. Six such MAs exist. In spite of the differences between MAs, it appears that RT does not add extra benefit to induction CHT administered before surgery, and that a trimodality (i.e. including surgery) regimen is not superior to definitive concurrent RT-CHT. While one can consider both induction CHT followed by surgery and exclusive concurrent RT-CHT as feasible in this setting, lack of pre-treatment predictive factors identifying patients who might preferentially benefit from a surgical approach limits its use to well-planned clinical trials.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/patologia , Carcinoma Pulmonar de Células não Pequenas/terapia , Neoplasias Pulmonares/patologia , Neoplasias Pulmonares/terapia , Terapia Combinada , Humanos , Metanálise como Assunto , Estadiamento de Neoplasias
13.
Ann Agric Environ Med ; 13(2): 235-42, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17195995

RESUMO

During the period of 2000-2004, 3,096 red foxes from the whole territory of the Slovak Republic were sampled and examined parasitologically for infections with Echinococcus multilocularis, causative agent of serious alveolar echinococcosis in humans. Relations between prevalence of the parasite in individual regions of Slovakia and some environmental factors were weighted. During the study period, great differences of prevalence and infection intensity were found on a regional level and significant between-year fluctuation of both parameters was observed. High-endemic foci with an estimated prevalence of more than 30 % were detected in the northern and central part of the country. Climatic conditions, including low mean annual air temperature, high mean annual rainfall and the high humidity of the soil, showed to be important for E. multilocularis distribution. Significant correlation was calculated between prevalence of the tapeworm, mean annual precipitation values, and population density of small mammals.


Assuntos
Animais Selvagens/parasitologia , Clima , Reservatórios de Doenças/veterinária , Equinococose/veterinária , Raposas/virologia , Animais , Reservatórios de Doenças/parasitologia , Equinococose/epidemiologia , Equinococose/parasitologia , Ensaio de Imunoadsorção Enzimática/veterinária , Interações Hospedeiro-Parasita , Humanos , Prevalência , Eslováquia/epidemiologia , Especificidade da Espécie
14.
Wiad Parazytol ; 52(3): 213-8, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17432245

RESUMO

INTRODUCTION: In the Slovak Republic, trichinellosis circulates almost exclusively in the sylvatic cycle, with main reservoir host red fox and wild boar and sporadic occurrence of human outbreaks. A detailed study was performed in five ecologically different regions of eastern Slovakia with more profound regard to eco-geographical and anthropogenic influences to natural fox habitat. MATERIAL AND METHODS: In total of 689 red foxes (Vulpes vulpes) hunted in selected regions in 2005/2006 was examined using artificial digestion method. Larvae obtained from infected samples were on the species level characterised using multiplex PCR analysis. RESULTS: The study revealed a total prevalence of 15.6%, with most frequent occurrence of infected foxes in the mountain of the Volovské Vrchy (25.2%) where both human habitation and fox population are very dense. High prevalence rates were found in the Kosická Kotlina Basin (19.6%) with urbanised landscape, concentrated human activities and low fox population and in national park of the High Tatras (15.8%) where the inhabitants and fox population are relatively low. In the remote localities of the Nízke Beskydy Highlands that represent ideal fox habitat free of any human impact, 14.2% of foxes harboured Trichinella larvae. The lowest occurrence of infected foxes (6.9%) was found in agrarian areas of the Východoslovenská Nizina Lowland, with relatively low inhabitants and fox population density. In all localities Trichinella britovi was the most important etiological agent of sylvatic trichinellosis.


Assuntos
Ecologia/classificação , Raposas/parasitologia , Helmintíase Animal/epidemiologia , Triquinelose/epidemiologia , Triquinelose/veterinária , Animais , Transmissão de Doença Infecciosa/veterinária , Ecologia/estatística & dados numéricos , Helmintíase Animal/transmissão , Interações Hospedeiro-Parasita , Humanos , Larva/classificação , Reação em Cadeia da Polimerase/veterinária , Prevalência , Eslováquia , Especificidade da Espécie , Trichinella/classificação , Trichinella/isolamento & purificação
15.
Acta Parasitol ; 61(2): 205-11, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-27078642

RESUMO

Trichinellosis, a parasitic zoonosis with world-wide distribution, causes serious health problems in humans and is also of economic importance. In Slovakia the most frequent species is T. britovi, causing disease mainly in wild life species. T. spiralis occurs less frequently and T. pseudospiralis only sporadically. The paper describes the epidemiology of six human Trichinella infection outbreaks recorded in Slovakia between 1980 and 2008. Before 1990 wild boar meat was the main source of infection. Later, risk farm practices, especially feeding of pigs with the wild animal´s offal contributed to the formation of synanthropic cycle and pig meat caused the epidemics in 1990, 2001 and 2008. Sausages prepared from pork and T. britovi infected dog meat and offered as a local food specialty on traditional folk festival in 1998 (Brezno district, Central Slovakia) were the source of the largest human outbreak recorded in Slovakia. The anti-Trichinella antibodies were detected in 336 event visitors. The main reason of repeated human epidemics in Slovakia has been the permanent circulation of Trichinella spp. in sylvatic cycle, especially in red foxes and wild boars. High population density of both animal species, persistent prevalence of trichinellosis in wild boars and even increasing positivity of red foxes suggest that the risk of human outbreaks in Slovakia persists.


Assuntos
Surtos de Doenças , Doenças Transmitidas por Alimentos/epidemiologia , Trichinella/isolamento & purificação , Triquinelose/epidemiologia , Animais , Humanos , Eslováquia/epidemiologia , Trichinella/classificação
16.
Clin Lung Cancer ; 17(2): 107-12, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26683387

RESUMO

Although a trimodality regimen for patients with stage IIIA/pN2 non-small-cell lung cancer (NSCLC) has been variably used owing to limited evidence for its benefits, it remains unknown whether any patient subgroup actually receives benefit from such an approach. To explore this question, the published data were reviewed from 1990 to 2015 to identify the possible predictors and prognosticators in this setting. Overall survival was the endpoint of our study. Of 27 identified studies, none had studied the predictors of improved outcomes with trimodality treatment. Of the potential patient- and tumor-related prognosticators, age, gender, and histologic type were the most frequently formally explored. However, none of the 3 was found to influence overall survival. The most prominent finding of the present review was the substantial lack of data supporting a trimodality treatment approach in any patient subgroup. As demonstrated in completed prospective randomized studies, the use of surgery for stage IIIA NSCLC should be limited to well-defined clinical trials.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/cirurgia , Pneumonectomia , Carcinoma Pulmonar de Células não Pequenas/mortalidade , Carcinoma Pulmonar de Células não Pequenas/patologia , Terapia Combinada , Humanos , Estadiamento de Neoplasias , Prognóstico , Ensaios Clínicos Controlados Aleatórios como Assunto , Medição de Risco , Fatores de Risco , Análise de Sobrevida , Resultado do Tratamento
17.
Pathol Res Pract ; 212(6): 524-31, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27013059

RESUMO

Most cases of cystic squamous cell carcinoma (SCC) metastases in the upper neck are associated with an oropharyngeal primary, namely human papillomavirus (HPV)-associated SCC arising in the palatine or lingual tonsil. A retrospective study was performed on 22 patients who presented with cystic head and neck SCC metastases. The purpose of the study was to find out whether histological characteristics, p16 protein expression, HPV and Epstein-Barr virus (EBV) status could be useful in predicting the localization of the primary tumor. The primary site was identified in 20 of 22 patients and included the oropharynx in 14 patients (63.6%), the nasopharynx in 3 patients (13.6%), the lungs in 2 cases (9%), and the skin of the auricle in one case (4.5%). No primary was found in two patients (9%). Sixteen of 17 cases (94.1%) originating in Waldayer's ring (oropharynx and nasopharynx), and both cases with an unknown primary showed morphology of non-keratinizing SCC or non-keratinizing SCC with maturation. All tumors with oropharyngeal primary and both cases with unknown primary showed diffuse p16 staining and presence of HPV DNA. All three cystic metastases of nasopharyngeal carcinoma were EBV-positive and p16/HPV-negative. In contrast, cutaneous and pulmonary metastases showed morphology of a well differentiated keratinizing SCC and poorly differentiated keratinizing SCC, respectively, and were HPV/EBV-negative. We confirmed that cystic SCC lymph node metastases of the head and neck region are strongly associated with the occult primary localized in the oropharynx. The oropharyngeal origin should always be corroborated by p16 immunohistochemistry and HPV-specific testing because SCC arising in other sites, such as nasopharynx, skin or lungs may manifest with cystic neck metastases as well. Addition of EBV testing in p16/HPV-negative cases can disclose the nasopharyngeal origin of the cystic neck metastases in a subset of cases.


Assuntos
Carcinoma de Células Escamosas/secundário , Neoplasias de Cabeça e Pescoço/secundário , Herpesvirus Humano 4/isolamento & purificação , Metástase Linfática/patologia , Neoplasias Primárias Desconhecidas/patologia , Papillomaviridae/isolamento & purificação , Adulto , Idoso , Carcinoma de Células Escamosas/virologia , Feminino , Neoplasias de Cabeça e Pescoço/virologia , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Primárias Desconhecidas/virologia
18.
J Clin Oncol ; 33(35): 4202-9, 2015 Dec 10.
Artigo em Inglês | MEDLINE | ID: mdl-26527790

RESUMO

PURPOSE: This multicenter phase III study evaluated the efficacy and safety of lapatinib, an epidermal growth factor receptor/ErbB2 inhibitor, administered concomitantly with chemoradiotherapy and as maintenance monotherapy in patients with high-risk surgically treated squamous cell carcinoma of the head and neck (SCCHN). PATIENTS AND METHODS: Patients with resected stage II to IVA SCCHN, with a surgical margin ≤ 5 mm and/or extracapsular extension, were randomly assigned to chemoradiotherapy (66 Gy total radiation dose and cisplatin 100 mg/m(2) per day administered on days 1, 22, and 43) plus placebo or lapatinib (1,500 mg per day) before and during chemoradiotherapy, followed by 12 months of maintenance monotherapy. RESULTS: Six hundred eighty-eight patients were enrolled (lapatinib, n = 346; placebo, n = 342). With a median follow-up time of 35.3 months, the study ended early because of the apparent plateauing of disease-free survival (DFS) events. Median DFS assessed by an independent review committee was 53.6 months and not reached for lapatinib and placebo, respectively (hazard ratio, 1.10; 95% CI, 0.85 to 1.43). Investigator-assessed results confirmed the independent review committee assessment. No significant differences in DFS by human papillomavirus status or overall survival were observed between treatment arms. Similar numbers of patients in both treatment arms experienced adverse events (AEs), with more patients in the lapatinib arm than the placebo arm experiencing serious AEs (48% v 40%, respectively). The most commonly observed treatment-related AEs were diarrhea and rash, both predominantly in the lapatinib arm. CONCLUSION: Addition of lapatinib to chemoradiotherapy and its use as long-term maintenance therapy does not offer any efficacy benefits and had additional toxicity compared with placebo in patients with surgically treated high-risk SCCHN.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma de Células Escamosas/terapia , Quimiorradioterapia , Neoplasias de Cabeça e Pescoço/terapia , Quimioterapia de Manutenção , Quinazolinas/uso terapêutico , Adulto , Idoso , Carcinoma de Células Escamosas/metabolismo , Cetuximab/administração & dosagem , Quimioterapia Adjuvante , Cisplatino/administração & dosagem , Intervalo Livre de Doença , Fracionamento da Dose de Radiação , Método Duplo-Cego , Receptores ErbB/efeitos dos fármacos , Receptores ErbB/genética , Feminino , Neoplasias de Cabeça e Pescoço/metabolismo , Humanos , Cooperação Internacional , Estimativa de Kaplan-Meier , Lapatinib , Masculino , Pessoa de Meia-Idade , Terapia de Alvo Molecular , Razão de Chances , Carcinoma de Células Escamosas de Cabeça e Pescoço , Resultado do Tratamento
19.
Acta Trop ; 85(2): 223-9, 2003 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-12606100

RESUMO

The present study was undertaken to characterize more thoroughly aetiological agent of cystic echinococcosis that still represents a health problem in the Slovak Republic. Sequencing of the mitochondrial ND1 gene, Random Amplified Polymorphic DNA (RAPD) analysis and isoenzyme analyses were used to characterize genetically protoscolices of 37 isolates from pigs and cattle and two isolates from humans collected in different regions of the Slovak Republic. Solely the G7 genotype (pig strain) was identified by ND1 sequences in all 14 pigs isolate examined by this method. This genotype was also found in two human patients and in two cattle. The exclusive finding of the G7 variant has implications for the implementation of control strategies given its unique developmental and biological properties. Despite striking morphological variability, a low degree of the intra-strain variability was found in the Slovak Echinococcus granulosus isolates with the genetic methods used. This was particularly associated with the shape and size of hooks, number of testes and shape of ovaries and uterus. GPI and MDH enzymes were found suitable for the discrimination of G7 and G1 (=cosmopolitan sheep strain) variant.


Assuntos
Equinococose/parasitologia , Echinococcus/anatomia & histologia , Echinococcus/genética , Animais , Sequência de Bases , Cães , Equinococose/epidemiologia , Isoenzimas/análise , População/genética , Eslováquia/epidemiologia
20.
Parasitol Int ; 53(4): 315-25, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15464441

RESUMO

Selected immunological parameters in healthy mice and mice infected with Echinococcus multilocularis and the effect of free and liposomized albendazole (lip.ABZ) upon these parameters in relation to the reduction of parasite growth were investigated over 26 weeks. Proliferative response of splenic T and B lymphocytes, number of CD4+ and CD8+ spleen T cell subpopulations, serum concentration of IFN-gamma and IL-5, and generation of superoxide anion (O2-) by peritoneal macrophages were the chosen parameters. Both drug forms were given to mice at a dose of 10 mg kg(-1) twice a week from week 4 to week 10 post infection (p.i.) (6 weeks in total). The reduction of cyst growth after treatment with ABZ and lip.ABZ was similar up to week 4 after last dose, but the parasitostatic effect of lip.ABZ lasted 4 weeks longer than the effect of free drug. After administration of both drug forms, the proliferative responses of T and B cells were restored, and also the number of CD4+ and CD8+ increased markedly. In lip.ABZ-treated mice, stimulation of mentioned lymphocyte parameters, except that of CD8+ numbers, persisted for longer period than after ABZ therapy, where values peaked at week 12 p.i., then declined more rapidly. A very strong stimulatory effect was seen on B lymphocytes during the period of lip.ABZ administration, although interestingly, numbers of CD8+ cells were higher in free ABZ-treated group. Low concentrations of IFN-gamma (Th1 response) were present in infected, untreated mouse serum. Only moderate IFN-gamma elevation was observed after treatment with free ABZ. A profound increase of its concentration was seen shortly after administration of lip.ABZ, and persisted until the experiment ended. In infected untreated mice, concentration of IL-5 (Th2 response) was highest on week 2 p.i. Significantly more IL-5 was recorded in serum of mice treated with free ABZ treatment than with lip.ABZ from week 12 to 18 p.i. (weeks 2-8 after the last dose). After the initial increase of superoxide anions (weeks 4-11 p.i.), generation of O2- by peritoneal macrophages was gradually inhibited by E. multilcoularis infection. In general, treatment abolished this suppression and macrophages from lip.ABZ-treated mice produced elevated amounts of O2- over a longer period than macrophages from ABZ-treated mice. Our data indicate that anthelmintic potency of ABZ could be increased after incorporation into liposomes, not only because of improved pharmacokinetics and consequent bioavailability, but also because of significant stimulation of Th1-type cytokine IFN-gamma response and effector macrophage functions.


Assuntos
Albendazol/uso terapêutico , Anti-Helmínticos/uso terapêutico , Equinococose/tratamento farmacológico , Equinococose/imunologia , Echinococcus multilocularis/crescimento & desenvolvimento , Lipossomos/uso terapêutico , Albendazol/administração & dosagem , Animais , Anti-Helmínticos/administração & dosagem , Linfócitos B/imunologia , Equinococose/parasitologia , Echinococcus multilocularis/efeitos dos fármacos , Interferon gama/metabolismo , Interleucina-5/metabolismo , Lipossomos/administração & dosagem , Ativação Linfocitária , Macrófagos Peritoneais , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Superóxidos/metabolismo , Linfócitos T/imunologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa